CompanyPrivateNeedham, MA

Remedium Bio Inc

SEC EDGAR ClinicalTrials.gov

NoneSEC filings in coverage

Form DAug 28$4.4M sold

August 2026

Imperial College London completes ACTION hypertension study in Nigeria and Sri Lanka

Aug 25Trial updateRemedium Bio Inc